HOME >> BIOLOGY >> NEWS
Blood pressure-lowering DASH diet also reduces homocysteine

The blood pressure-lowering DASH diet also reduces levels of the amino acid homocysteine, according to a National Heart, Lung, and Blood Institute (NHLBI)-funded study. A high level of homocysteine appears to increase the risk of heart disease, stroke, and peripheral vascular disease.

The study appears in the August 22 issue of Circulation: Journal of the American Heart Association.

DASH stands for Dietary Approaches to Stop Hypertension. This new report is based on data from the DASH trial, which found that a diet rich in fruits, vegetables, and lowfat dairy foods and low in saturated fat, total fat, and cholesterol significantly and quickly lowers blood pressure. The diet also included whole grains, poultry, fish, and nuts.

The DASH trial involved four sites and a coordinating center. The homocysteine results come from the Johns Hopkins University site in Baltimore, MD.

Homocysteine levels are affected by various factors, including intake of folic acid (or folate) and vitamins B6 and B12. In the trial, participants followed one of three dietsa control diet similar to what most Americans eat, a diet rich in fruits and vegetables, and the DASH diet. Compared with homocysteine levels of those on the control diet, homocysteine levels of those on the DASH diet were significantly lower, with levels of those on the fruits and vegetables diet being intermediate. Changes in the homocysteine levels were significantly associated with changes in folate levels.


'"/>

Contact: NHLBI Communications Office
301-496-4236
NIH/National Heart, Lung, and Blood Institute
21-Aug-2000


Page: 1

Related biology news :

1. Blood pressure hormone may inhibit growth of lung cancer
2. Blood tests identify patients on dialysis at high risk for death from cardiovascular disease
3. Blood banking systems improving in China, more progress needed
4. Blood proteins tied to inflammation
5. Bloodworms way with copper likely provides paradigm for new materials
6. Blood markers may reflect newborns potential of contracting HIV
7. Blood stem cells carry targeted genes
8. Blood vessels trigger development of the pancreas
9. Blood vessels found to signal chain of destruction in bone diseases
10. Blood markers associated with autism and mental retardation
11. Blood test for diagnosing schizophrenia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life Sciences , ... announces a new solution to manage regulated workloads on Microsoft Azure. , Regulated ... stack complies with FDA and global regulations. USDM's new managed service for regulated ...
(Date:7/18/2020)... ... 2020 , ... Commercial launch readiness is a critical stage in a product ... or vaccine, the global economic downturn will only increase price pressures overall for the ... capturing full value from every product launch is critical. However, history shows that only ...
(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient MasterClass ... is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of savory ... at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting & ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... sciences industry, today announced the release of its signature product called Beacon ... Liaisons (MSLs) and other field medical professionals. , Beacon helps MSLs ...
(Date:7/18/2020)... MILWAUKEE (PRWEB) , ... July 16, 2020 , ... “We ... at Third Wave Bioactives. “It’s the only technology of its kind on the market ... flavor of onions with the protective capacity of traditional cultured ingredients, creating a natural ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, a ... laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume ... Bode-CARES provides a turnkey solution that includes a comprehensive collection and virus-management ...
(Date:7/10/2020)... Mass. (PRWEB) , ... July 09, 2020 , ... ... approaches to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., ... team and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. ...
Breaking Biology Technology:
Cached News: